Market Research

Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. For more, visit: https://www.marketsandmarkets.com

Tensiometer Market To Reach USD 151 Million By 2024 – Growing Demand For Cosmetics Industry

The global market for tensiometer global market for tensiometer global market for tensiometer is primarily driven by the need to improve product quality and manufacturing processes, increasing pharmaceutical and biopharmaceutical R&D expenditure, and technological advancements. However, the reluctance to switch from conventional methods and a dearth of skilled personnel will challenge market growth.

[131 Pages Report] The global tensiometer market is expected to reach USD 151 million by 2024 from an estimated value of USD 103 million in 2019, growing at a CAGR of 7.9% during the forecast period.

This study on the global tensiometer market involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices

2. Pressure to Reduce Volume of Regulated Medical Waste

On the basis of product, the tensiometer market is segmented into optical tensiometers, force tensiometers, volumetric tensiometers, bubble pressure tensiometers, and accessories. The optical tensiometers segment accounted for the largest market share in 2018. The large share of this segment is mainly attributed to the large adoption of optical tensiometers in the chemical, oil & gas, energy, pharmaceutical, and material & coating industries in the R&D and quality control of products.

Download PDF Brochure@  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10015314 

The geographical regions mapped in the report are:

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, Asia Pacific accounted for the largest share of the tensiometer market. The factors such as chemical production growth in China, growth in Indian oil & gas industry, increasing demand for primary energy in India, and growth in medical device & pharmaceutical market in Asia are driving the growth of the tensiometer industry in this region.

Some key players mentioned in the research report are:

The key players in the global tensiometer market are KRÜSS GmbH (Germany), DataPhysics Instruments GmbH (Germany), Biolin Scientific AB (Sweden), Kyowa Interface Science Co. Ltd. (Japan), LAUDA Scientific GmbH (Germany), TECLIS Scientific (France), Apex Instruments Co. Pvt. Ltd. (India), Pro-Pack Materials (Singapore), USA KINO Industry Co. Ltd. (US), and Kibron Inc. Oy (Finland).

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=10015314 

Dental Impression Systems Market : Analysis of Worldwide Industry Trends and Opportunities

According to the new market research report “ Dental Impression Systems Market by Product (Impression Material, Intraoral Scanners, Trays), Application (Restorative and Prosthodontics Dentistry, Orthodontics), End User (Hospitals, Dental Laboratories, Forensic Laboratories) – Global Forecast to 2025″, published by MarketsandMarkets™, global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period.

Major Growth Drivers:

The growth in the dental impression systems market is mainly driven by factors such as the rising incidence of dental diseases, increasing demand for cosmetic dentistry. In addition, growing dental tourism in emerging markets and rising adoption of digital dentistry are expected to drive demand growth in the dental impression systems market during the forecast period.

Expected Revenue Growth:

[171 Pages Report] The global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period.

Covid-19 Impact on the Dental impression systems Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities on a daily basis. As of December 2020, 63.8 million cases of COVID-19 have been reported across Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in approximately 1.5 million deaths. With the COVID-19 pandemic, most countries, including the whole of Europe, the US, India, and Australia, among others, are following complete nationwide lockdowns. This also affected the supply chain for dental impression materials and scanners.

By product, segment, the intraoral scanners segment is expected to grow at the highest growth rate during the forecast period

Among the product, segment, the intraoral scanners segment is expected to grow at the highest CAGR during the forecast period. The intraoral scanners segment is estimated to grow at the highest CAGR during the forecast period as these scanners increase the accuracy of dental impressions and reduce the time involved in procedures.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256609208 

Asia-Pacific is the fastest growing market for dental impression systems market during the forecast period

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high growth in this regional market can be attributed to the rising patient volume, growing medical tourism, and increasing disposable incomes.

Key Market Players

The major players in the global dental impression systems market are 3M (US), Henry Schein (US), Dentsply Sirona (US), Mitsui Chemicals (Japan), and Envista (US). Other prominent players in this market include Parkell, Inc. (US), Kettenbach GmbH & Co. KG (Germany), Zest Dental Solutions (US), Keystone Industries (US), Ultradent Products, Inc. (US), Septodont Holding (US), GC Corporation (US), DETAX (Germany), Kerr Corporation (US), Ivoclar Vivadent (US), Kuraray Co. Ltd. (Japan), BEGO (Germany), Premier Dental Products Company (US), and DMG America (US).

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=256609208 

Source: http://www.marketsandmarkets.com/Market-Reports/dental-impression-system-market-256609208.html

Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer

Major Growth Drivers:

Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays. On the other hand, Uncertain reimbursement scenario in different regions is expected to restrain the growth of this market during the forecast period.

Expected Revenue Growth:

[116 Pages Report] The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period.

Recent Developments: 

1. In May 2018, Adaptive Biotechnologies (US) collaborated with Sanofi, SA. (US), to utilize Adaptive’s clonoSEQ Assay to measure MRD status in response to isatuximab2. In July 2018, Abbott Laboratories (US) received FDA approval for its Abbott RealTime IDH1 kit3. In May 2018, Invivoscribe, Inc. (US) partnered with the American University of Beirut Medical Center (AUBMC) (Lebanon) to create a new center of excellence facility in the Middle East

Browse in-depth TOC on “Hemato Oncology Testing Market

77 – Tables29 – Figures116 – Pages

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=262472877 

“The services segment accounted for the largest share of the hemato oncology testing in 2018”

Based on product & services, the hemato oncology testing is segmented into services and assay kits. In 2018, the services segment accounted for the largest share of the hemato oncology testing. This is mainly due to the increasing prevalence & incidence of leukemia, non-Hodgkin lymphoma, and myeloma cancers. Apart from this, rising awareness regarding advanced treatment therapies such as personalized medicine is also driving the growth of this segment.

“Asia Pacific to register the highest growth rate during the forecast period (2019–2024)”

Based on region, the hemato oncology testing is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). While North America dominated the market in 2018, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC market is driven mainly by the large patient population, and increasing focus of major players on expanding in this region will drive market growth.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=262472877 

Key Market Players

Prominent players in the hemato oncology testing market include F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Germany), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), MolecularMD (Ireland), Invivoscribe, Inc. (US), Asuragen, Inc. (US), Adaptive Biotechnologies (US), ArcherDx, Inc. (US), and ARUP Laboratories Inc. (US).

Source: http://www.marketsandmarkets.com/Market-Reports/hemato-oncology-testing-market-262472877.html

Genotyping Assay Market Worth USD 31.9 Billion : Increasing Application Areas Of Genotyping

MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (OTC:CAGR) of 22.0% during the forecast period.

The sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices2. Pressure to Reduce Volume of Regulated Medical Waste

The report analyzes the market by product & service, type of medical device, application, and region. On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.

Download PDF Brochure@   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595 

The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period. The increasing demand for pharmacogenomics in the drug discovery and development process and recommendations from the FDA to include genotyping and pharmacogenomics studies in the course of drug discovery have contributed to the growth of this market segment.

The geographical regions mapped in the report are:

North America is expected to hold the largest market size in the global genotyping market during the forecast period, followed by the European region. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

Some key players mentioned in the research report are:

Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Request for sample pages
@   https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595 

Source: http://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

Autoinjectors Market Worth $ 104.9 Billion : Rising Incidence Of Anaphylaxis

Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market.

[180 Pages Report] The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025.

Market Dynamics

  • Growing prevalence of targeted therapies
  • Rising incidence of anaphylaxis
  • Increasing number of regulatory approvals
  • Availability of generic versions of autoinjectors
  • Favorable reimbursements and government support
  • Ease of use increasing the preference for self-administration

COVID-19 Impact on The Autoinjectors Market

The COVID-19 pandemic has resulted in a global healthcare crisis, causing a shift in healthcare delivery in most regions. Most non-essential procedures and in-hospital therapies were deferred in the first half of 2020 to prevent the spread of the infection and ease the toll on healthcare infrastructure. According to researchers at Indiana University, healthcare visits decreased by around 40% in the first six weeks of the pandemic in the US, from early March to mid-April. After restrictions were eased, there has been an overall decline in patients delaying seeking care and treatment in healthcare settings.

In summary, the COVID-19 pandemic has been accelerating the trend of self-injection, empowering patients to have more involvement and control over their treatment. Newer technologies in the autoinjectors market have encouraged this trend, as they allow better management of injection speed, injection site pain, and treatment anxiety.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724 

Opportunity: Need to limit patient visits and physical contact

The current COVID-19 pandemic has resulted in the implementation of a fresh set of protocols that aim to reduce patient visits to hospitals and clinics in non-emergency conditions to prevent both the transmission of the virus as much as make sure healthcare institutions are not overwhelmed. In this situation, the preference for home-use autoinjectors has risen among patients suffering from chronic illnesses and allergies. This also protects vulnerable high-risk populations from exposure to the virus during hospital visits.

Autoinjectors are being developed to support increased viscosity and concentrations of drugs to reduce administration frequency, thus increasing adherence to recommended drug protocols. These factors present an opportunity for the growth of the autoinjectors market in the current COVID-19 scenario.

The geographical regions mapped in the report are:

Geographically, the autoinjectors market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the Asia Pacific market is majorly driven by the large diabetes population and increasing healthcare expenditure which has drawn a number of major autoinjector device manufacturers to this region. These companies are increasing their presence in the Asia Pacific market through several approaches, such as establishing sales offices and partnering with local pharmaceutical companies

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724 

Patient Access Solutions Market Worth USD 2.4 Billion : Growing Importance Of Denials Management

According to the new market research report ”Patient Access Solutions Market by product & service (Training services, Eligibility Verification, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End-User (Providers, HCIT Outsourcing Companies) – Global Forecast to 2025“,published by MarketsandMarkets™, global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.

Major Growth Drivers:

Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market. However, high deployment costs are expected to restrain the growth of this market to a certain extent.

Expected Revenue Growth:

[207 Pages Report] The global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.

Browse in-depth TOC on “Patient Access Solutions Market”

103 – Tables58 – Figures207 – Pages

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=280473

Healthcare Providers was the largest end-user for the Patient access solutions market in 2019

Based on end-users, the patient access solutions market is segmented into healthcare providers, HCIT outsourcing companies, and other end users. In 2019, the healthcare providers segment accounted for the largest share of the global patient access solutions market. Growing HCIT adoption, significant growth in healthcare spending, increasing healthcare costs, and declining reimbursement rates are the major factors supporting the adoption of patient access solutions among healthcare providers.

APAC market to witness the highest growth during the forecast period

The Asia Pacific market is comparatively new to patient access solutions; however, this region is expected to register the highest growth in the coming years. Countries such as Japan, Australia, New Zealand, South Korea, and Singapore are expected to provide significant growth opportunities for vendors of patient access solutions.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=280473

Key Market Players

The market is dominated by a few globally established players such as McKesson (US), Cerner (US), Optum (US), 3M (US) and Experian Plc (Ireland)

Source: http://www.marketsandmarkets.com/Market-Reports/patient-access-solution-market-280473.html

Esoteric Testing Market : Future Of Mass Spectrometry, It Is Creating Real Change In The Medical Device Industry

According to the new market research report ”Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) – Global Forecast to 2023“, published by MarketsandMarkets™, MarketsandMarkets forecasts the global esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%.

Major Growth Drivers:

The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The objective of the report is to define, describe, and forecast the esoteric testing market size based on type, technology, laboratory type, and regions.

Expected Revenue Growth:

[223 Pages Report] MarketsandMarkets forecasts the global esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%.

Accessories to Fuel the Growth of Esoteric Testing Market :

The MnM repository is referred to for high-level insights into the esoteric testing market. Each of the technologies, types, and end users involved in the esoteric testing services were analyzed through secondary research and validated with primary interviews. MnM also identified the key service providers in this market for the assigned countries and conducted interviews with the key industry experts to arrive at the market splits and shares. MnM triangulated all of this data to estimate the market size and forecast the growth of this market.

Browse in-depth TOC on “Esoteric Testing Market

110 – Tables

37 – Figures223 – Pages

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708 North America to account for the largest market size during the forecast period.

North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, development in healthcare infrastructure, and significant rise in the disposable income in the region.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708 

LabCorp (US), Quest Diagnostics (US), OPKO Health (US), Miraca Holdings (US), ARUP Laboratories (US), Myriad Genetics (US), Genomic Health (US), American Medical Laboratories (US), Foundation Medicines (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (UK), Fulgent Genetics (US), Spectra Laboratories (US), Nordic Lifesciences (US), InVitae (US), Unilabs (Switzerland), and SYNLAB (Germany).

Source: http://www.marketsandmarkets.com/Market-Reports/esoteric-testing-market-76794708.html

Cryotherapy Market To Reach USD 319 Million – Statistics & Growth Dynamics to 2024

What This Report Will Provide?

The study involved four major activities to estimate the current size of the cryotherapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Expected Revenue Growth:

[120 Pages Report] The cryotherapy market is expected to grow from USD 206 million in 2019 to USD 319 million by 2024, at a CAGR of 9.1% during the forecast period.

Major Growth Boosters:

Growth in the cryotherapy market is primarily driven by factors such as the growing incidences of sports injuries, cardiac diseases, & cancers, and technological advancements in cryotherapy technology.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=33280524

Recent Developments

  • In 2019, Medtronic collaborated with Phillips (Netherlands) to facilitate the sale of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures, for the advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder.
  • Kriosystem Life was the official supplier of cryotherapy devices for The World Games 2017, held in Wroclaw, Poland

Critical questions the report answers:

  • Which of the product segments will dominate the cryotherapy market in the next five years?
  • Emerging countries have immense opportunities for the growth and adoption of cryotherapy, will this scenario continue in the next five years?
  • Increasing availability and awareness of advanced technology in the emerging market is impacting the growth for developed markets. How will the pricing difference impact the overall market?
  • What are the upcoming technologies in the cryotherapy market?
  • Which application segment will dominate the cryotherapy market in the next five years?

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=33280524  

Technological Advancements in cryotherapy equipment

Cryotherapy has become an important treatment option, mainly due to the various technological innovations and advancements in cryotherapy equipment over the years. Developments have been observed in various equipment, including cryosurgery units and accessories. Cryochambers and cryosaunas, which are widely used in the treatment of inflammation, rheumatoid arthritis, and pain management, along with general beauty and wellness therapies, have also undergone developmental enhancements.

Regional Growth Analysis:

North America held the largest share of the market in 2018 and is projected to continue to do so during the forecast period. Factors such as the growing popularity of cryotherapy, rising prevalence of cancer, increase in sports and physical activity-related injuries, and rising prevalence of CVDs are driving the North American cryotherapy market. Lately, the US has seen a growing popularity of cryotherapy among athletes and fitness & beauty enthusiasts, leading to many professional and collegiate training departments installing cryosauna machines at their facilities.

Source: http://www.marketsandmarkets.com/Market-Reports/cryotherapy-market-33280524.html

COVID-19 Impact On Global Drug Screening Market : Growing Drug & Alcohol Consumption

Major Growth Drivers:

Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches.

According to the new market research report ” Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™ , global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

Expected Revenue Growth:

[192 Pages Report] The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

COVID-19 impact on the drug screening market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773 

The rapid testing devices segment will witness the highest growth during the forecast period.

Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2019. 

North America was the largest regional market for drug screening market in 2019.

The drug screening market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773 

Key Market Players

The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Alere (US), OraSure (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

Source: http://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html

Infectious Disease Diagnostics Market Worth $39.8 Billion By 2026

What This Report Will Provide?

This study involved four major activities in estimating the current size of the infectious disease diagnostics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[263 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a CAGR of 7.2%.

Major Growth Boosters:

Market growth is driven by the global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589 

COVID-19 Impact on Global Infectious Disease Diagnostics Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies but had an positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents.

Recent Developments

  • In March 2021, Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.
  • In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.
  • In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589 

Driver: Global prevalence of infectious diseases and onset of COVID-19The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, is expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics; hence, it is expected to have a positive impact on this market.

Regional Growth Analysis:

The global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market. The North American infectious disease diagnostics market's growth can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

Source: http://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html

US Anticoagulation Therapy Market Worth USD 27.83 Billion : Growth In The Geriatric Population

The anticoagulation therapy market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. The in-office devices segment dominated the US anticoagulation therapy market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services. However, the home testing devices segment is expected to grow at the highest CAGR due to its advantages such as convenience, time & cost savings, and quick result generation. Additionally, the cost of test devices and the tests themselves are often reimbursable.

What This Report Will Provide?

The high cost of NOACs and requirement of significant investments in the development of anticoagulation drugs are the major factors restraining the growth of this market. In addition, the growth in the anticoagulation clinics market is primarily driven by the increasing prevalence of cardiovascular diseases & blood disorders, high level of medication adherence associated with clinics, and rising aging population.

Expected Revenue Growth:

[86 Pages Report] The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%

Major Growth Boosters:

The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs).

Market growth is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs).

Download PDF Brochure:    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114158575

Years considered for this report :

  • 2016 – Base Year
  • 2017 – Estimated Year
  • 2022 – Projected Year

Key Questions Addressed in The Report:

  • To define, describe, and forecast the market on the basis of anticoagulation drugs, PT/INR testing devices, and anticoagulation clinics
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, and industry-specific opportunities)
  • To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall US anticoagulation therapy industry
  • To forecast the size of the US anticoagulation therapy market
  • To profile key market players in the US anticoagulation market
  • To track and analyze competitive developments such as product launches and approvals in the market

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=114158575

Source: http://www.marketsandmarkets.com/requestsampleNew.asp?id=114158575

Residential Air Purifiers Market To Reach USD 13.6 Billion By 2025 | CAGR : 8.2%

The need for an energy-efficient air purifier and R&D being undertaken to bring innovative products to the market is aiding the market growth. However, the high cost of these products and technical limitations associated with air quality monitoring products are expected to restrain the growth of this market during the forecast period.

What the Market Looks Like?

The residential air purifiers market is projected to reach USD 13.6 billion by 2025 from USD 9.2 billion in 2020, at a CAGR of 8.2% during the forecast period.The Asia Pacific market accounts for largest market share for residential air purifiers in 2019

The growth of this market is majorly driven by the growing popularity of smart homes, supportive government regulations for effective air pollution monitoring and control, increasing public-private funding for effective air pollution monitoring, rising levels of air pollution worldwide, and increasing public awareness related to the healthcare and environmental implications of air pollution.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40172748

COVID-19 Impact on Global Residential Air Purifiers Market

According to our findings, the residential air purifiers market is expected to grow at an approximate CAGR of 8-10% during the next two years. According to our analysis, the below factors are playing a key role in shaping the growth of the global market;

The COVID-19 outbreak has generated major remunerative opportunities for air purifier manufacturers, with high-performance units, comprising HEPA and activated carbon technologies, being highly popular, to minimize the spread of the virus for enclosed spaces. Premium, high-performance air purifiers are capable of filtering out particles up to 1 micron, and the size of the COVID-19 virus is estimated to be around 1.2 microns. Consequently, manufacturers have displayed confidence in being able to provide a solution for indoor environments, during the outbreak, which will sustain demand for the near future.

What Drives the Market?

The growth of the Residential Air Purifiers Market is primarily influenced by the following factors:

  • Growing popularity of smart homes
  • Increasing urbanization and indoor air pollution
  • Supportive government regulations for effective air pollution monitoring and control
  • Increasing public awareness pertaining to the healthcare implications of air pollution

The growing awareness among consumers regarding air purification in the wake of COVID-19 is an opportunity for air purifier retailers to scale up their sales. Some companies are increasing the production of air quality systems with the addition of different technologies such as High-Efficiency Particulate Air (HEPA) filters, photocatalytic purifiers, activated carbon purifiers, and ionic filters.

Driver: Growing popularity of smart homes

Smart connected homes are equipped with smart devices that enable residents to control or program an array of automated home electronic devices/products remotely through a smartphone. Smart homes are usually equipped with devices, such as detectors and sensors, to monitor, analyze, and control the quality of air indoors. When the air quality is below the desired level, the sensors intimate the residents of impurities in the air and signal the air quality monitors to start purifying the air.

Read more about Residential Air Purifiers Market@  https://www.marketsandmarkets.com/requestsampleNew.asp?id=40172748

Source: http://www.marketsandmarkets.com/Market-Reports/residential-air-purifiers-market-40172748.html

Medical Device Reprocessing Market – Statistics and Growth Dynamics To 2022

Expected Revenue Growth:

The global medical device reprocessing market is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016.

What This Report Will Provide?

The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent.

Major Growth Boosters:

The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat multiple patients.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=583 

Objectives of the Study

  • To define, describe, and forecast the global market with respect to product & service, type of device, application, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
  • To forecast the size of the market with respect to four main regions—North America, Europe, Asia-Pacific, and the Rest of the World

Target Audience:

  • Third-party medical device reprocessors and distributors
  • Hospitals, clinics, and other healthcare laboratories
  • Academic and research institutions
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=583  

The reprocessing practices are regulated by various regional regulatory authorities. The changing regulatory scenario favoring medical device reprocessing in a number of countries, such as France and Japan, will open up new areas of opportunity for market players. For example, till 2016, the outsourcing of medical device reprocessing was prohibited in France; however, the European Union (EU) Regulations (Article 17), released on April 5, 2017, mandated the use of third-party reprocessing services by all French hospitals.

Regional Growth Analysis:

Geographically, the global medical device reprocessing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to its well-established healthcare industry, growing prevalence of chronic diseases, and increasing volume of surgical procedures. The European region is expected to witness the highest CAGR during the forecast period, owing to the rising prevalence of chronic diseases, increasing geriatric population, rising healthcare expenditure, increasing number of surgical procedures, and growing awareness about the usage of reprocessed medical devices

Source: http://www.marketsandmarkets.com/Market-Reports/reprocessed-refurbished-medical-devices-market-583.html

IV Equipment Market To Progress At A Healthy CAGR In Coming Years

Expected Revenue Growth:

The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.

What This Report Will Provide?

The global burden of chronic diseases such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes is increasing rapidly. According to the World Health Organization (WHO) 2015, chronic diseases accounted for approximately 60% of the total reported deaths in the world. The proportion of the burden of chronic diseases (chronic non-communicable diseases) is expected to increase to 57% by 2020 from 46% in 2001.

Major Growth Boosters:

Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Presently, many companies are developing various infusion devices capable of being integrated with alarm devices, monitoring devices, and data exchange systems. This integration helps prevent an overdose or reduced dose of infusion solutions to patients and minimizes dosing errors.

Download PDF Brochure:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=78345313 

Objectives of the Study

  • To define, describe, and forecast the global IV equipment market on the basis of product, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and trends)
  • To strategically analyze micromarkets1 and subsegments with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
  • To forecast the size of the IV equipment market, with respect to four main regions—North America, Europe, Asia-Pacific, and the Rest of the World

Major Market Developments

  • In 2015, Becton, Dickinson and Company acquired CareFusion Corporation (US). The combination of these two companies’ complementary product portfolios offered integrated medication management solutions and smart devices, including infusion pumps.
  • In 2017, BD launched a new IV medication safety solution at the European Association of Hospital Pharmacists (EAHP, Cannes) congress to improve patient safety. This product is designed to prevent medication administration errors.
  • In October 2017, ICU Medical, Inc. acquired Pfizer's Hospira infusion systems (HIS, U.S.) business segment with a comprehensive portfolio of complete IV therapy from pumps to solutions.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=78345313 

Increasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this market.

Regional Growth Analysis:

The IV equipment market in APAC is expected to grow at the highest CAGR during the forecast period. The demand for IV equipment and accessories in the APAC region is majorly driven by factors such as the large population base in the region, rising geriatric population, rising incidence of chronic diseases, improving accessibility to advanced healthcare facilities, rising healthcare spending, growing penetration of health insurance, increasing demand for advanced technologies, growing investments in emerging APAC countries by key market players, and expansion of private-sector hospitals to rural areas.

Source: http://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html

Radiation Dose Management Market To Reach USD 423 Million By 2025 – Increasing Investment In Computed Tomography

What This Report Will Provide?

The study involved four major activities to estimate the current size of the radiation dose management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth:

[226 Pages Report] The global radiation dose management market size is projected to reach USD 423 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9% during the forecast period.

Major Growth Boosters:

Growth of the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344 

COVID -19 IMPACT ON THE RADIATION DOSE MANAGEMENT MARKET

Several countries across the globe have seen non-urgent diagnostic imaging surgeries being postponed due to the pandemic. These procedures utilize additional resources and increase the risk of complications; depending on the procedure, they also increase the chance of needing equipment, resources, or materials such as hospital beds and PPE.

Key developments:

  • In 2018, Sectra AB launched Sectra Dosetrack.
  • In 2018, Sectra AB launched Gadolinium Tracking in its dose monitoring solution.
  • In 2017, DOSE, Qaelum's dose management solution, expanded its reach in radiology and medical imaging departments in the UK.

The radiation dose management solutions segment is expected to grow at the highest CAGR during the forecast period

Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services. The radiation dose management solutions segment is projected to witness the highest growth during the forecast period. The increasing adoption of radiation dose management solutions by healthcare providers owing to the growing regulations regarding ionizing radiation across the globe is the major factor supporting the growth of this segment.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=82326344 

Growing concerns over radiation exposure

In the last two decades, radiation exposure to patients has increased significantly. This can be attributed to the growing use of radiological procedures such as CT, fluoroscopy, and interventional imaging procedures, coupled with an increase in the radiation doses used in these procedures. In diagnostic imaging modalities, higher tube currents are used for obese patients to improve image quality. Owing to this, the risk of radiation overexposure for obese patients is high.

Regional Growth Analysis:

Based on the region, the radiation dose management market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the radiation dose management market. The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety.

Source: http://www.marketsandmarkets.com/Market-Reports/radiation-dose-management-market-82326344.html

Pharmacy Automation Market To Reach USD 5.38 Billion By 2022 – Increasing Investment In Retail Pharmacy

Expected Revenue Growth:

[218 Pages Report] MarketsandMarkets forecasts the pharmacy automation market is estimated to grow from USD 3.63 billion in 2017 to USD 5.38 Billion by 2022, at a Compound Annual Growth Rate (OTC:CAGR) of 8.2% during the forecast period.

What This Report Will Provide?

The systems for managing medicines have remained largely unchanged for decades, while medications have increased in number and complexity, resulting in potentially greater risks for error. In addition, with the traditional methods of operation within pharmacies, pharmacists have witnessed various issues such as an increase in medication errors and growing patient waiting times, due to the increasing patient load.

Major Growth Boosters:

The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost. On the other hand, reluctance among the healthcare organizations to adopt pharmacy automation systems is expected to restrain the overall market growth to a certain extent during the forecast period.

The objective of the report is to define, describe, and forecast the pharmacy automation market size based on product, end user, and region.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71522890  

Recent Developments :

  • In 2017, Omnicell launched Omnicell VBM 200F. It fills and checks SureMed multiple medication blister cards
  • In 2017, Omnicell partnered with DCH Health Systems to implement a full suite of IV compounding technology across its health system
  • In 2017, BD opened its new institute for medication management excellence. This institute is designed to identify and support advancements in medication management to help improve the safety and cost of healthcare
  • In 2016, Omnicell acquired Ateb, Inc., which provides pharmacy-based patient care solutions and medication synchronization to independent and chain pharmacies
  • In 2015, BD acquired CareFusion Corporation, a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room & procedural effectiveness, and respiratory care

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the pharmacy automation market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading players operating in this market?
  • What are the opportunities for new market entrants?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=71522890

Growing need to minimize medication errors :

Medication errors and dispensing errors are recognized as leading causes of hospital readmissions across the globe. A medication error can occur due to a variety of factors such as poor order communication between the physician and pharmacist, dangerous storage practices in pharmacies, and confusion arising out of the use of similar labels. Automated systems are considered to be one of the most efficient solutions to minimize these errors.

Regional Growth Analysis:

North America is expected to hold the largest market size in the pharmacy automation market during the forecast period, followed by the European region. The large share of the North American pharmacy automation market can largely be attributed to the increasing number of drug prescriptions at pharmacies resulting from growth in the aging population. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America and also the presence of a large number of pharmacy automation companies.

Source: http://www.marketsandmarkets.com/Market-Reports/pharmacy-automation-systems-market-71522890.html